Literature DB >> 6361037

Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases.

M C Faugere, H H Malluche.   

Abstract

UNLABELLED: In this study we evaluated different biopsy techniques for the quantitative study of bone histology. Bone biopsies were done using an electric drill and a Jamshidi needle after tetracycline double-labeling in patients with renal bone disease, osteoporosis, or Paget's disease. Bone slides were stained with Masson-Goldner stain and evaluated for quantitative static and dynamic parameters of bone structure, formation, and resorption. Statistical evaluation of the differences and correlations between histomorphometric parameters obtained from slides of bone samples thirty-five millimeters long and five or three millimeters in diameter revealed that three-millimeter samples were sufficient for qualitative diagnosis but were not optimum for the quantitative evaluation of cellular parameters of resorption and dynamic parameters of formation. A useful compromise might be the use of a four-millimeter specimen obtained with the less invasive technique that hitherto has been employed only for smaller samples. CLINICAL RELEVANCE: Several bone-biopsy techniques are available that provide bone samples of different sizes. Knowledge of the smallest sample size that is sufficient for qualitative and quantitative diagnosis of metabolic bone diseases will help the physician to select the least-invasive techniques without losing relevant information.

Entities:  

Mesh:

Year:  1983        PMID: 6361037

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  10 in total

1.  Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.

Authors:  Hartmut H Malluche; Hanna W Mawad; Marie-Claude Monier-Faugere
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

2.  Comparison of two bone trephine instruments used for quantitative histomorphometry.

Authors:  R J Moore; T C Durbridge; A E Woods; B Vernon-Roberts
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

3.  Prevalence of low bone formation in untreated patients with osteoporosis.

Authors:  Hartmut H Malluche; Daniel L Davenport; Florence Lima; Marie-Claude Monier-Faugere
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

4.  Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.

Authors:  G Francini; R Petrioli; A Aquino; S Gonnelli
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Hypercalcemia in breast cancer.

Authors:  G Francini; R Petrioli; E Maioli; S Gonnelli; S Marsili; A Aquino; S Bruni
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

Review 6.  Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  David W Dempster; Juliet E Compston; Marc K Drezner; Francis H Glorieux; John A Kanis; Hartmut Malluche; Pierre J Meunier; Susan M Ott; Robert R Recker; A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

Review 7.  Percutaneous, Imaging-Guided Biopsy of Bone Metastases.

Authors:  Dimitrios Filippiadis; Argyro Mazioti; Alexios Kelekis
Journal:  Diagnostics (Basel)       Date:  2018-04-18

Review 8.  Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future.

Authors:  Pascale Chavassieux; Roland Chapurlat
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

9.  Mineral bone disease in autosomal dominant polycystic kidney disease.

Authors:  Berenice Gitomer; Renata Pereira; Isidro B Salusky; Jason W Stoneback; Tamara Isakova; Xuan Cai; Lorien S Dalrymple; Norma Ofsthun; Zhiying You; Harmut H Malluche; Franklin Maddux; Diana George; Vicente Torres; Arlene Chapman; Theodore I Steinman; Myles Wolf; Michel Chonchol
Journal:  Kidney Int       Date:  2020-09-11       Impact factor: 10.612

10.  Weekly chemotherapy in advanced prostatic cancer.

Authors:  G Francini; R Petrioli; A Manganelli; M Cintorino; S Marsili; A Aquino; S Mondillo
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.